Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report ; volume:8 ; number:1 ; day:23 ; month:10 ; year:2014 ; pages:1-3 ; date:12.2014
Journal of medical case reports ; 8, Heft 1 (23.10.2014), 1-3, 12.2014
- Creator
-
Noriega Aldave, Adrian P.
- Contributor
-
Jaiswal, Shikha
SpringerLink (Online service)
- DOI
-
10.1186/1752-1947-8-353
- URN
-
urn:nbn:de:1111-201607113384
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Noriega Aldave, Adrian P.
- Jaiswal, Shikha
- SpringerLink (Online service)
Other Objects (12)
Zoledronic acid targets chemo-resistant polyploid giant cancer cells
Multiple myeloma
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Imaging of Multiple Myeloma
Severe abdominal pain and diarrhea – unusual multiple myeloma presentation with a severe prognosis: a case report
SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
New therapies in multiple myeloma
Leptomeningeal metastasis of multiple myeloma
Zoledronic acid targets chemo-resistant polyploid giant cancer cells
Multiple myeloma
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Imaging of Multiple Myeloma
Severe abdominal pain and diarrhea – unusual multiple myeloma presentation with a severe prognosis: a case report
SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
New therapies in multiple myeloma
Leptomeningeal metastasis of multiple myeloma
Zoledronic acid targets chemo-resistant polyploid giant cancer cells
Multiple myeloma
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Imaging of Multiple Myeloma
Severe abdominal pain and diarrhea – unusual multiple myeloma presentation with a severe prognosis: a case report
SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
New therapies in multiple myeloma